Body weight slashed by 20% in new anti-obesity drug trial
Preliminary data from a large Phase 3 clinical trial is offering promising signs for a new anti-obesity drug. Called tirzepatide, the drug helped overweight and obese participants lose up to 22.5 percent of their total body weight over 72 weeks. Source of Article